About this trial
This is a prospective randomized controlled trial comparing two ways of delivering Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR) therapy for posttraumatic stress disorder (PTSD). The study seeks 60 volunteers who have PTSD and are eligible for care in the Department of Defense healthcare system. There will be 10-14 therapy sessions that are 60-90 minutes long, about once a week, and symptoms will be assessed before and after the therapy as well as 3 and 6 months after completing therapy. 3MDR asks you to choose pictures and music that are integrated into a virtual reality environment. You will be walking on a treadmill throughout each therapy session, while the therapist stands next to the treadmill and asks you questions about the pictures you chose.
Eligibility criteria
Qualifiers
Service member, veteran, retiree, or DEERS-eligible dependent, male or female, at least 18 years or older
Diagnosis of PTSD, as confirmed by the CAPS-5
Able to ambulate with contact guard assistance or less, and walk unassisted on a treadmill, at a normal pace, for up to 90 minutes continuously
Disqualifiers
History of epilepsy or a seizure disorder, other than febrile seizures that occurred during childhood and have not recurred since
History of a psychotic disorder, bipolar disorder, or active suicidal or homicidal ideation
Use of benzodiazepines on a regular basis within the previous 30 days
Trial design
Treatments tested in this trial
- Motion-assisted, Multi-modular Memory Desensitization and Reconsolidation (3MDR)
Treatment groups
Sponsors and collaborators
Uniformed Services University of the Health Sciences
Lead sponsor
Military Traumatic Brain Injury Initiative, USUHS
Collaborator
Center for Rehabilitation Sciences Research, USUHS
Collaborator